鲁棒多细胞程序解析结直肠腺癌的复杂肿瘤微环境并追踪疾病进展
Robust multicellular programs dissect the complex tumor microenvironment and track disease progression in colorectal adenocarcinomas
AI总结:
本研究结合MIBI与机器学习,以单细胞分辨率解析结直肠病变的多维度TME特征,构建MuVIcell框架挖掘协同驱动疾病进展的多细胞程序,为靶向TME治疗及其他实体瘤研究提供支撑。
摘要:
结直肠癌(CRC)具有高度异质性,其五年生存率从局限性疾病的约90%降至发生远处转移时的约15%。疾病进展不仅由肿瘤内在改变决定,还受肿瘤微环境(TME)重构的影响。代谢、组成和空间变化均参与这一进展过程,但单独考量时缺乏背景关联性,且往往无法成为有效的治疗靶点。理解这些变化的协同作用,或能发现可改变疾病进程的生物学过程。本研究将多路离子束成像(MIBI)与机器学习相结合,以单细胞分辨率解析了522个结直肠病变的代谢、功能和空间状态。我们观察到复发性的分期特异性重构,其特征为淋巴样细胞向髓样细胞的转变、基质-癌细胞协同作用以及恶性细胞代谢偏移。上皮、基质和免疫区室的空间组织结构,对疾病分期的分层能力优于仅靠肿瘤内在改变或 bulk 免疫浸润的方法。为系统建模这些协同变化,我们将多模态特征浓缩为10个TME组织的潜在因子。这些因子可追踪疾病进展,在不同队列中具有保守性,还揭示了常见的多细胞代谢微环境以及不同的、非互斥的TME演化轨迹。我们的框架MuVIcell通过将跨细胞类型和特征类别的共现变化归类为协同的多细胞程序,揭示了共同驱动CRC进展的要素,为靶向TME重构的治疗策略提供了合理基础。重要的是,该框架具备可扩展性和灵活性,为研究其他实体瘤的多细胞组织结构提供了资源。
英文摘要:
Colorectal cancer (CRC) is highly heterogeneous, with five-year survival rates dropping from $\sim$90% in localized disease to $\sim$15% with distant metastases. Disease progression is shaped not only by tumor-intrinsic alterations but also by the reorganization of the tumor microenvironment (TME). Metabolic, compositional, and spatial changes contribute to this progression, but considered individually they lack context and often fail as therapeutic targets. Understanding their coordination could reveal processes to alter the disease course. Here, we combined multiplexed ion beam imaging (MIBI) with machine learning to profile metabolic, functional and spatial states of 522 colorectal lesions with single-cell resolution. We observed recurrent stage-specific remodeling marked by a lymphoid-to-myeloid shift, stromal-cancer cooperation, and malignant metabolic shifts. Spatial organization of epithelial, stromal, and immune compartments provided stronger stratification of disease stage than tumor-intrinsic changes or bulk immune infiltration alone. To systematically model these coordinated changes, we condensed multimodal features into 10 latent factors of TME organization. These factors tracked disease progression, were conserved across cohorts, and revealed frequent multicellular metabolic niches and distinct, non-exclusive TME trajectories. Our framework MuVIcell exposes the elements that together drive CRC progression by grouping co-occurring changes across cell types and feature classes into coordinated multicellular programs. This creates a rational basis to therapeutically target TME reorganization. Importantly, the framework is scalable and flexible, offering a resource for studying multicellular organization in other solid tumors.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。